Clinical studies at Sanquin

Between 2011 and 2022, the patient-oriented research of Sanquin Blood Supply was organized from the joint Sanquin - Leiden University Medical Center Jon J van Rood Center for Clinical Transfusion Research.

Clinical studies (alphabetical order)

For information on a clinical study please contact the principal investigator of the studies listed below or send an email to Sanquin Research.

  • ABLE, Age of Blood Evaluation
  • ATTACH, Analysis of Thrombocyte Transfusion in Cardiothoracic surgery and Hematology
  • Bite Study, Bleeding In Thrombocytopenia Explained
  • BloodMatch, The balance between patients’ need and supply of matched red cells.
  • DRAIHA Study, Databank and Registry for AutoImmune Hemolytic Anemia
  • DTD, Dutch Transfusion Data Warehouse (formerly PROTON II)
  • EPO Rh4 Study
  • FIBER, Fibrin Induced Blood Exposure Reduction
  • First, use of Fibrin Sealant in total knee replacement surgery trial
  • FROSTED, FResh frozen plasma, Omniplasma & SDP comparison of Trans­fu­sion reactions, Efficacy & DVT study
  • INFLAME, INFLAMmatory Injury of the Lung after Cardiac SurgEry
  • INOX-ICU, INsuf­fi­cient OXygen supply in ICU patients
  • INOX-ICU 2, Insuf­fi­cient Oxygen Supply in ICU patients II
  • LISBOA, Leiden Implementation Study of Blood management in hip and knee Arthroplasties
  • LOTUS, LOng Term follow-Up after intra-uterine trans­fu­sionS
  • Match, Preventive extended red blood cell antigen MATCHing: when and how
  • MATER, Mortality After Transfusion of Ever-pregnant donor Red blood cells
  • MATISSE, MAnaging Trombocyte transfusion In a Special Subgroup: nEonates
  • MONET, Monitoring Outcome in NEonatal Thrombocytopenia
  • OPTIMAL, Optimize Transfusion Support in Hematological Malignancies
  • PREPAReS, Pathogen Reduction Evaluation & Predictive Analytical Rating Score
  • R-FACT, Risk factors for alloim­mu­niza­tion after red blood cell trans­fu­sions
  • Sex-mismatch, Sex-mismatched trans­fu­sions and recipient mortality
  • STAR
  • TeMpOH, Trans­fu­sion strategies in women during Major Obstetric Hemorrhage
  • TeMpOH2, Trans­fu­sion strategies in women during Major Obstetric Hemorrhage
  • TOMaat, Transfusie Op Maat ( allogeneic red blood cell sparing alternatives)
  • WOMB, Trans­fu­sion require­ments after postpartum hemorrhage